#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	15824	16S	1529	1529	100.0	16S.l15.c17.ctg.1	2262	836.4	1	SNP	n	C1184T	0	.	.	1184	1184	C	1442	1442	C	1020	C	1020	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27094	23S	2890	2890	99.9	23S.l6.c4.ctg.1	4155	814.1	0	.	n	.	0	T695C	SNP	695	695	T	1273	1273	C	942	C,T	940,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27094	23S	2890	2890	99.9	23S.l6.c4.ctg.1	4155	814.1	0	.	n	.	0	G1337A	SNP	1337	1337	G	1915	1915	A	1145	A	1145	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27094	23S	2890	2890	99.9	23S.l6.c4.ctg.1	4155	814.1	0	.	n	.	0	T1971C	SNP	1971	1971	T	2549	2549	C	981	C,G,A	979,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27094	23S	2890	2890	99.9	23S.l6.c4.ctg.1	4155	814.1	1	SNP	n	A2045G	0	.	.	2045	2045	A	2623	2623	A	906	A,G	905,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27094	23S	2890	2890	99.9	23S.l6.c4.ctg.1	4155	814.1	1	SNP	n	C2597T	0	.	.	2597	2597	C	3175	3175	C	1009	C,A,G	1005,3,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27094	23S	2890	2890	99.9	23S.l6.c4.ctg.1	4155	814.1	0	HET	.	.	.	C1075T,A	.	1075	1075	C	1653	1653	C	1001	C,T,A	751,249,1	.	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	2194	folP	855	855	100.0	folP.l15.c17.ctg.1	1992	137.4	1	SNP	p	R229S	1	.	.	685	687	AGC	1267	1269	AGC	213;207;206	A;G;C,G	213;207;204,2	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5674	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3910	181.0	1	SNP	p	S91F	1	.	.	271	273	TTC	909	911	TTC	202;204;205	T;T,C;C,A	202;203,1;204,1	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5674	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3910	181.0	1	SNP	p	D95G	1	.	.	283	285	GGC	921	923	GGC	209;208;212	G;G,A;C	209;206,2;212	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5674	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3910	181.0	1	SNP	p	G95N	0	.	.	283	285	GGC	921	923	GGC	209;208;212	G;G,A;C	209;206,2;212	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	27	2158	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1906	141.4	1	SNP	p	G45D	0	.	.	133	135	GGC	760	762	GGC	258;258;260	G,C;G;C	257,1;258;260	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	1128	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1456	96.8	0	.	n	.	0	A197.	DEL	197	197	A	795	795	A	217	A,T	216,1	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5406	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3588	188.0	1	SNP	p	D86N	0	.	.	256	258	GAC	900	902	GAC	247;245;242	G;A,C;C	247;244,1;242	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5406	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3588	188.0	1	SNP	p	R87W	0	.	.	259	261	CGT	903	905	CGT	239;240;242	C;G;T	239;240;242	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5406	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3588	188.0	1	SNP	p	R87I	0	.	.	259	261	CGT	903	905	CGT	239;240;242	C;G;T	239;240;242	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5406	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3588	188.0	1	SNP	p	S87R	1	.	.	259	261	CGT	903	905	CGT	239;240;242	C;G;T	239;240;242	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5406	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3588	188.0	1	SNP	p	S88P	0	.	.	262	264	TCC	906	908	TCC	239;242;243	T;C;C	239;242;243	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4446	parE	1986	1986	100.0	parE.l6.c4.ctg.1	3113	178.1	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1769	1771	GGC	231;230;231	G,C;G,A;C,T	230,1;229,1;230,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	4214	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2920	180.0	1	SNP	p	A311V	0	.	.	931	933	GCA	1505	1507	GCA	235;232;230	G;C;A	235;232;230	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4214	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2920	180.0	1	SNP	p	I312M	0	.	.	934	936	ATC	1508	1510	ATC	230;235;236	A,G;T;C	229,1;235;236	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4214	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2920	180.0	1	SNP	p	V316P	0	.	.	946	948	GTG	1520	1522	GTG	249;250;248	G,A;T;G	248,1;250;248	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4214	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2920	180.0	1	SNP	p	V316T	0	.	.	946	948	GTG	1520	1522	GTG	249;250;248	G,A;T;G	248,1;250;248	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4214	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2920	180.0	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2024	2026	ACC	245;247;244	A;C;C,A	245;247;243,1	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4214	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2920	180.0	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2078	2080	GCG	208;209;212	G;C;G,C	208;209;211,1	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4214	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2920	180.0	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2078	2080	GCG	208;209;212	G;C;G,C	208;209;211,1	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4214	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2920	180.0	1	SNP	p	G543S	1	.	.	1627	1629	AGC	2201	2203	AGC	202;199;200	A;G,C;C	202;198,1;200	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4214	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2920	180.0	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2210	2212	GGC	195;197;197	G;G;C,T	195;197;196,1	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4214	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2920	180.0	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2228	2230	CCG	198;197;194	C;C,A;G	197;195,1;193	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5856	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3493	209.0	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1763	1765	CCG	242;243;244	C;C;G,A	242;243;243,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2588	porA	1146	1146	99.91	porA.l15.c17.ctg.1	2385	135.4	0	.	p	.	0	M83fs	FSHIFT	247	247	A	899	899	C	178	C,T	177,1	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	326	porB1a	984	226	90.27	porB1a.l15.c17.ctg.1	537	22.6	0	.	p	.	0	V258L	NONSYN	772	774	GTA	14	16	TTA	25;26;27	T;T;A	25;26;27	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	326	porB1a	984	226	90.27	porB1a.l15.c17.ctg.1	537	22.6	0	.	p	.	0	Y273H	NONSYN	817	819	TAT	59	61	CAT	64;64;64	C;A;T	64;64;64	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	326	porB1a	984	226	90.27	porB1a.l15.c17.ctg.1	537	22.6	0	.	p	.	0	D274S	NONSYN	820	822	GAT	62	64	AGT	64;64;64	A;G;T	64;64;64	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	326	porB1a	984	226	90.27	porB1a.l15.c17.ctg.1	537	22.6	0	.	p	.	0	N277Y	NONSYN	829	831	AAC	71	73	TAC	64;64;64	T;A;C	64;64;64	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	326	porB1a	984	226	90.27	porB1a.l15.c17.ctg.1	537	22.6	0	.	p	.	0	R307A	NONSYN	919	921	AGA	161	163	GCA	1;1;1	G;C;A	1;1;1	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	326	porB1a	984	226	90.27	porB1a.l15.c17.ctg.1	537	22.6	0	.	p	.	0	T311A	NONSYN	931	933	ACA	173	175	GCA	1;1;1	G;C;A	1;1;1	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	326	porB1a	984	226	90.27	porB1a.l15.c17.ctg.1	537	22.6	0	.	p	.	0	E312D	NONSYN	934	936	GAA	176	178	GAC	2;2;2	G;A;C	2;2;2	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	326	porB1a	984	226	90.27	porB1a.l15.c17.ctg.1	537	22.6	0	.	p	.	0	F314I	NONSYN	940	942	TTC	182	184	ATC	2;2;2	A;T;C	2;2;2	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	326	porB1a	984	226	90.27	porB1a.l15.c17.ctg.1	537	22.6	0	.	p	.	0	A316S	NONSYN	946	948	GCG	188	190	TCG	3;4;4	T;C;G	3;4;4	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	326	porB1a	984	226	90.27	porB1a.l15.c17.ctg.1	537	22.6	0	.	p	.	0	V318A	NONSYN	952	954	GTC	194	196	GCC	4;4;4	G;C;C	4;4;4	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	326	porB1a	984	226	90.27	porB1a.l15.c17.ctg.1	537	22.6	0	.	p	.	0	G319S	NONSYN	955	957	GGC	197	199	AGC	4;4;5	A;G;C	4;4;5	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	326	porB1a	984	226	90.27	porB1a.l15.c17.ctg.1	537	22.6	0	.	p	.	0	G320A	NONSYN	958	960	GGT	200	202	GCC	5;5;5	G;C;C	5;5;5	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	326	porB1a	984	226	90.27	porB1a.l15.c17.ctg.1	537	22.6	0	.	p	.	0	G322V	NONSYN	964	966	GGT	206	208	GTT	5;5;5	G;T;T	5;5;5	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	326	porB1a	984	100	94.0	porB1a.l15.c17.ctg.4	177	60.6	0	.	p	.	0	M18T	NONSYN	52	54	ATG	128	130	ACG	75;71;70	A;C;G	75;71;70	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	326	porB1a	984	100	94.0	porB1a.l15.c17.ctg.4	177	60.6	0	.	p	.	0	E32Q	NONSYN	94	96	GAA	170	172	CAA	18;16;11	C;A;A	18;16;11	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3224	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1767	222.8	0	.	p	.	0	N38E	NONSYN	112	114	AAT	501	503	GAA	278;275;271	G;A;A,C	278;275;270,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3224	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1767	222.8	0	.	p	.	0	N134D	NONSYN	400	402	AAT	789	791	GAT	271;269;270	G,A;A;T	270,1;269;270	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3224	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1767	222.8	0	.	p	.	0	P175S	NONSYN	523	525	CCA	912	914	TCA	266;269;267	T,G;C;A	265,1;269;267	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3224	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1767	222.8	0	.	p	.	0	A218V	NONSYN	652	654	GCC	1041	1043	GTC	282;282;279	G;T,A;C	282;281,1;279	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3224	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1767	222.8	0	.	p	.	0	F222S	NONSYN	664	666	TTT	1053	1055	TCT	278;281;283	T;C;T	278;281;283	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3224	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1767	222.8	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1371	1373	GCA	259;258;265	G;C,T;A,C	259;257,1;264,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3224	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1767	222.8	1	SNP	p	G120K	1	.	.	358	360	AAG	747	749	AAG	276;275;276	A;A,C;G,A	276;274,1;275,1	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3224	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1767	222.8	1	SNP	p	A121D	1	.	.	361	363	GAC	750	752	GAC	273;271;273	G;A,G;C	273;270,1;273	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3224	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1767	222.8	1	SNP	p	D121N	0	.	.	361	363	GAC	750	752	GAC	273;271;273	G;A,G;C	273;270,1;273	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10558	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5388	244.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1600	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1607	124.4	1	SNP	p	V57M	1	.	.	169	171	ATG	782	784	ATG	304;307;304	A,T;T,C;G	303,1;306,1;304	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
